Headache

British Medical Journal

Volumn 325, Issue 7369, 2002, Pages 881-886

  Steiner, T J ^a   Fontebasso, Manuela ^b  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b Front Street Surgery ^*  (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ALMOTRIPTAN; AMITRIPTYLINE; ANALGESIC AGENT; ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; ELETRIPTAN; ERGOTAMINE; ERGOTAMINE TARTRATE; ESTROGEN; IBUPROFEN; LITHIUM CARBONATE; MEFENAMIC ACID; METHYSERGIDE; NARATRIPTAN; ORAL CONTRACEPTIVE AGENT; PARACETAMOL; PIZOTIFEN; PREDNISOLONE; PROPRANOLOL; RIZATRIPTAN; SUMATRIPTAN; VALPROIC ACID; VERAPAMIL; ZOLMITRIPTAN;

CLINICAL FEATURE; CLUSTER HEADACHE; DISABILITY; DISEASE PREDISPOSITION; HEADACHE; HUMAN; MIGRAINE; PHYSICAL EXAMINATION; PRIORITY JOURNAL; QUALITY OF LIFE; REVIEW; TENSION HEADACHE;

ANALGESICS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; DIAGNOSIS, DIFFERENTIAL; HEADACHE DISORDERS; HUMANS;

EID: 0037137079     PISSN: 09598146     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (27)

1. Hopkins A, Menken M, De Friese GA. A record of patient encounters in neurological practice in the United Kingdom. J Neurol Neurosurg Psychiatry 1989;52:436-8.
2. Wiles CM, Lindsay M. General practice referrals to a department of neurology. J R Coll Physicians Lond 1996;30:426-31.
3. Osterhaus JT, Gutterman DL, Plachetka JR. Healthcare resource and lost labour costs of migraine headache in the US. Pharmacoeconomics 1992;2:67-76.
4. Kryst S, Scherl E. A population-based survey of the social and personal impact of headache. Headache 1994;34:344-50.
5. American Association for the Study of Headache, International Headache Society. Consensus statement on improving migraine management. Headache 1998;38:736.
6. World Health Organization. The World Health Report 2001. Mental Health: New Understanding, New Hope. Geneva: WHO, 2001.
7. Headache Classification Committee of the International Headache Society. Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Cephalalgia 1988;8(suppl 7):1-96S.
8. Olesen J, Tfelt-Hansen P, Welch KMA, eds. The Headaches. 2nd Ed. Philadelphia: Lippincott-Raven, 2000.
9. Frishberg BM, Rosenberg JH, Matchar DB, McCrory DC, Pietrzak MP, Rozen TD, et al. Evidence-Based Guidelines in the Primary Care Setting: Neuroimaging in Patients with Nonacute Headache. American Academy of Neurology 2000.aan.com/professionals/practice/ (accessed 20 Sep 2002).
10. Ferrari MD. Migraine. Lancet 1998;351:1043-51.
11. Smetana GW. The diagnostic value of historical features in primary headache syndromes: A comprehensive review. Arch Intern Med 2000;160:2729-37.
12. Rasmussen BJ, Jensen R, Schroll M, Olesen J. Epidemiology of headache in a general population - A prevalence study; J Clin Epidemiol 1991;44:1147-57.
13. Schwartz BS, Stewart WF, Simon D, Lipton RB. Epidemiology of tensiontype headache. JAMA 1998;279:381-3.
14. Castillo J, Munoz P, Guitera V, Pascual J. Epidemiology of chronic daily headache in the general population. Headache 1999;39:190-6.
15. Srikiatkhachorn A, Phanthurachinda K. Prevalence and clinical features of chronic daily headache in a headache clinic. Headache 1997;37:277-80.
16. Limmroth V, Kazarawa Z, Fritsche G, Diener H-C. Headache after frequent use of serotonin agonists zolmitriptan and naratriptan. Lancet 1999;353:378.
17. Steiner T. Daily grind. Chemist & Druggist 2000;253: no. 6225 (continuing education programme supplement) v-viii (5 February). www.dotpharmacy.com/updaily.html (accessed 20 Sep 2002).
18. Silberstein SD, Lipton RB, Solomon S, Mathew NT. Classification of daily and near-daily headaches: Proposed revisions to the 1HS criteria. Headache 1994;34:1-7.
19. Lance F, Parkes C, Wilkinson M. Does analgesic abuse cause headaches de novo? Headache 1988;28:61-2.
20. Diener H-C, Dichgans J, Scholz E, Geiselhart S, Gerber WD, Bille A. Analgesic-induced chronic headache: Long-term results of withdrawal therapy. J Neurol 1989;236:9-14.
21. British Association for the Study of Headache. Guidelines for all Doctors in the Diagnosis and Management of Migraine and Tension-Type Headache. 2001. www.bash.org.uk (accessed 17 Sep 2002).
22. Ramadan NM, Schultz LL, Gilkey SJ. Migraine prophylactic drugs: Proof of efficacy, utilization and cost. Cephalalgia 1997;17:73-80.
23. Mulleners WM, Whitmarsh TE, Steiner TJ. Noncompliance may render migraine prophylaxis useless, but once-daily regimens are better. Cephalalgia 1998;18:52-6.
24. MacGregor EA. Menstruation, sex hormones and headache. Neurol Clin 1997;15:125-41.
25. Duarte RA, Thornton DR. Short-acting analgesics may aggravate chronic headache pain. Am Fam Physician 1995;203.
26. Schnider P, Aull S, Baumgartner C, Marterer A. Wöber C, Zeiler K, et al. Long-term outcome of patients with headache and drug abuse after inpatient withdrawal: Five-year follow-up. Cephalalgia 1996;16:481-5.
27. Hering R, Steiner TJ. Abrupt outpatient withdrawal of medication in analgesic-abusing migraineurs. Lancet 1991;337:1442-3.